Cost-Effectiveness Analysis of Panitumumab+Mfolfox over Bevacizumab+Mfolfox as a First-Line Treatment for Metastatic Colorectal Cancer Patients with Wild-Type Ras in Greece

Autor: Nikolaos Maniadakis, V. Papagiannopoulou, G Tritaki, Georgia Kourlaba, Z. Saridaki, I. Boukovinas

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9732fbb5c7d47df8799d4acc65cd1d59
https://pubmed.ncbi.nlm.nih.gov/27202252

The Cost of Tiotropium 5MCG + Olodaterol 5MCG In The Management Of Copd In Greece

Autor: H Kousoulakou, Ioulia Papageorgiou, G Tritaki, Kyriakos Souliotis

Publikováno v: Value in Health. 20:A642

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ccd3ef1b75154c66e44af08c7a07d61
https://doi.org/10.1016/j.jval.2017.08.1471

Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Breast Cancer In Greece

Autor: Guillermo Villa, G Gourzoulidis, V. Papagiannopoulou, Nikolaos Maniadakis, Gary H. Lyman, I Athanasiadis, G Tritaki, Georgia Kourlaba, G Aravantinos

Publikováno v: Value in Health. 18:A456

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a36e6c53c0429f02ecd6f778b01d92e0
https://doi.org/10.1016/j.jval.2015.09.1166

The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone Metastases

Autor: Jindrich Finek, Petra Jandová, G Tritaki, F Gatta, DP Zahn, L Bolognese, R Ikenberg, J. Cristino, C Moser, M Perez Encinas, Guy Hechmati, N. Maniadakis, I Campos Tapias

Publikováno v: Value in Health. 18:A483

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b886503c4a5e973619c7f43d5fadf2
https://doi.org/10.1016/j.jval.2015.09.1317

Cost Consequence Analysis Of Darbepoetin Alfa For The Treatment Of Anemia Due To Chronic Kidney Disease (Ckd) In Greece.

Autor: Kourlaba G; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece., Boletis I; Medical School of Athens, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Goumenos D; Nephrology and Renal Transplantation Department, Patras University Hospital,, Patras, Greece., Iatrou C; General Hospital of Nikaia, Athens, Greece., Papagiannopoulou V; AMGEN Hellas, Marousi, Greece., Tritaki G; AMGEN Hellas, Marousi, Greece., Maniadakis N; National School of Public Health, Athens, Greece.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A468-9. Date of Electronic Publication: 2014 Oct 26.